Iconovo is a company headquartered in Sweden. Brouky records 2 investors associated with the company.
Iconovo develops and licenses complete inhalation products, including both the drug formulation and the inhaler device, to pharmaceutical companies. Their goal is to make inhalation treatment more accessible to patients.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.